Clinical Trial Update: Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates intramyocardial injection of autologous umbilical cord blood-derived mononuclear cells during surgical repair of Hypoplastic Left H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Autologous umbilical cord blood-derived mononuclear cells (umbilical cord blood-derived mononuclear cells)

Snippet

Sponsor: Timothy J Nelson, MD, PhD | Conditions: Hypoplastic Left Heart Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-08